Document is current
Any future updates will be listed below
-
Authors
Schlaudecker, Elizabeth P. https://orcid.org/0000-0001-5280-4439
Jensen, Travis L. https://orcid.org/0000-0002-0322-0469
Gelber, Casey E.
Dexheimer, Phillip J.
Steinhoff, Mark C.
Bernstein, David I. https://orcid.org/0000-0002-0100-1991
Goll, Johannes B.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (N01 AI 80006, HHSN272200800013C, 75N93021C00012, HHSN272200800013C, 75N93021C00012, N01 AI 80006, N01 AI 80006, HHSN272200800013C, 75N93021C00012)
- License Information
-
More Information
Article History
Received: 13 September 2023
Accepted: 12 January 2025
First Online: 20 March 2025
Change Date: 23 May 2025
Change Type: Update
Change Details: The GEO accession number (GSE281592) has been added to the Data Availability statement. The original article has been corrected.
Competing interests
: Dr. Schlaudecker has received funding from Pfizer and the Centers for Disease Control and Prevention to conduct clinical research studies. She has received support from Sanofi Pasteur as a member of an advisory committee. All other authors declare no competing interests.
